BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 213489)

  • 1. Differences in activation of human and guinea pig complement by retroviruses.
    Bartholomew RM; Esser AF
    J Immunol; 1978 Nov; 121(5):1748-51. PubMed ID: 213489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of antibody-independent activation of the first component of complement (Cl) on retrovirus membranes.
    Bartholomew RM; Esser AF
    Biochemistry; 1980 Jun; 19(13):2847-53. PubMed ID: 6772208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
    Schultz DR; Arnold PI
    J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex.
    Bartholomew RM; Esser AF
    J Immunol; 1977 Dec; 119(6):1916-22. PubMed ID: 915287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits.
    Müller W; Hanauske-Abel H; Loos M
    J Immunol; 1978 Oct; 121(4):1578-84. PubMed ID: 701808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
    Bartholomew RM; Esser AF; Müller-Eberhard HJ
    J Exp Med; 1978 Mar; 147(3):844-53. PubMed ID: 632750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat virus-mediated suppression of leukemia induction by Moloney virus in rats.
    Bergs VV
    Cancer Res; 1969 Sep; 29(9):1669-72. PubMed ID: 5822476
    [No Abstract]   [Full Text] [Related]  

  • 19. EAC4 and EAC14 production without purified Ci.
    Linscott WD
    J Immunol; 1975 Dec; 115(6):1625-30. PubMed ID: 241767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of C1s-induced vascular leakage in guinea pigs by substituted benzamidine and pyridinium compounds.
    Andrews JM; Rosen FS; Silverberg SJ; Cory M; Schneeberger EE; Bing DH
    J Immunol; 1977 Feb; 118(2):466-71. PubMed ID: 320260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.